{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:28:05Z","timestamp":1789684085144,"version":"4.0.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Chief Scientist Office, Edinburgh, Scotland"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Feasibility of pharmacist delivered motivational interviewing (MI) to methadone patients has been demonstrated, but its efficacy is untested. This study aimed to determine whether pharmacists trained in MI techniques can improve methadone outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cluster randomised controlled trial by pharmacy, with community pharmacies across Scotland providing supervised methadone to &amp;gt;10 daily patients, aged &amp;gt;18 years, started on methadone &amp;lt;24 months. Pharmacies were randomised to intervention or control. Intervention pharmacists received MI training and a resource pack. Control pharmacists continued with normal practice. Primary outcome was illicit heroin use. Secondary outcomes were treatment retention, substance use, injecting behaviour, psychological\/physical health, treatment satisfaction and patient feedback. Data were collected via structured interviews at baseline and 6 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Seventy-six pharmacies recruited 542 patients (295 intervention, 247 control), mean age 32 years; 64% male; 91% unemployed; mean treatment length 9 months. No significant difference in outcomes between groups for illicit heroin use (32.4% cf. 31.4%), although within-groups use reduced (P &amp;lt; 0.001); treatment retention was higher in the intervention group but not significantly (88% cf. 81%; P = 0.34); no significant difference between groups in treatment satisfaction, although this improved significantly in intervention (P &amp;lt; 0.05). More intervention than control patients said pharmacists had \u2018spoken more,\u2019 which approached statistical significance (P = 0.06), and more intervention patients found this useful (P &amp;lt; 0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Limited intervention delivery may have reduced study power. The intervention did not significantly reduce heroin use, but there are indications of positive benefits from increased communication and treatment satisfaction.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/ijpp.12049","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T07:11:36Z","timestamp":1372921896000},"page":"4-12","source":"Crossref","is-referenced-by-count":26,"title":["Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial"],"prefix":"10.1093","volume":"22","author":[{"given":"Mariesha","family":"Jaffray","sequence":"first","affiliation":[{"name":"Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Matheson","sequence":"additional","affiliation":[{"name":"Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M","family":"Bond","sequence":"additional","affiliation":[{"name":"Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J","family":"Lee","sequence":"additional","affiliation":[{"name":"Medical Statistics Team, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"McLernon","sequence":"additional","affiliation":[{"name":"Medical Statistics Team, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Johnstone","sequence":"additional","affiliation":[{"name":"Advantage Training Consultancy, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Skea","sequence":"additional","affiliation":[{"name":"Substance Misuse, NHS Grampian, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Davidson","sequence":"additional","affiliation":[{"name":"Substance Misuse, NHS Grampian, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,7,3]]},"reference":[{"key":"2021020207082245400_ijpp12049-bib-0001","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/pubmed\/fdm064","article-title":"Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitudes over a decade in Scotland","volume":"29","author":"Matheson","year":"2007","journal-title":"J Public Health (Oxf)"},{"key":"2021020207082245400_ijpp12049-bib-0002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S1352465809005128","article-title":"Ten things motivational interviewing is not","volume":"2009","author":"Miller","year":"2009","journal-title":"Behav Cogn Psychother"},{"key":"2021020207082245400_ijpp12049-bib-0003","volume-title":"The Transtheoretical Approach: Crossing Traditional Boundaries of Therapy","author":"Prochaska","year":"1984"},{"key":"2021020207082245400_ijpp12049-bib-0004","first-page":"91","article-title":"The efficacy of motivational interviewing: a meta-analysis of controlled trials","volume":"1","author":"Burke","year":"2003","journal-title":"Consul Clin Psychol"},{"key":"2021020207082245400_ijpp12049-bib-0005","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.addbeh.2007.05.004","article-title":"Individual-level intervention to reduce college student drinking: a meta-analytic review","volume":"32","author":"Carey","year":"2007","journal-title":"Addict Behav"},{"key":"2021020207082245400_ijpp12049-bib-0006","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/alcalc\/agl016","article-title":"The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review","volume":"41","author":"Vasilaki","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"2021020207082245400_ijpp12049-bib-0007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/IJAMH.2006.18.1.53","article-title":"Motivational interviewing with adolescents and young adults for drug-related problems","volume":"18","author":"Grenard","year":"2006","journal-title":"Int J Adolesc Med Health"},{"key":"2021020207082245400_ijpp12049-bib-0008","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1037\/a0023992","article-title":"Effectiveness of motivational interviewing for adolescent substance use behavior change: a meta-analytic review","volume":"79","author":"Aylward","year":"2011","journal-title":"J Consult Clin Psychol"},{"key":"2021020207082245400_ijpp12049-bib-0009","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1049731509347850","article-title":"Meta-analysis of Motivational interviewing: twenty five years of research","volume":"20","author":"Lundahl","year":"2010","journal-title":"Res Soc Work Pract"},{"key":"2021020207082245400_ijpp12049-bib-0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1891\/jcop.18.4.299.64003","article-title":"Talking onself into change: motivational interviewing, stages of change and therapeutic process","volume":"18","author":"Miller","year":"2004","journal-title":"J Cogn Psychother"},{"key":"2021020207082245400_ijpp12049-bib-0011","volume-title":"Motivational Interviewing [Third Edition]: Helping People Change","author":"Miller","year":"2012"},{"key":"2021020207082245400_ijpp12049-bib-0012","volume-title":"Enhanced Community pharmacy Activities for Methadone Maintained Patients Based on Behavioural Change and Motivational Interviewing: a pilot study","author":"Matheson","year":"2006"},{"key":"2021020207082245400_ijpp12049-bib-0013","volume-title":"Behaviour Change Counselling Index (BECCI): Manual for Coding Behaviour Change Counselling","author":"","year":"2002"},{"key":"2021020207082245400_ijpp12049-bib-0014","first-page":"43","article-title":"Enhanced pharmacy services for patients on methadone maintenance therapy- attitudes and expectations of pharmacists","volume":"18","author":"Jaffray","year":"2010","journal-title":"Int J Pharm Pract"},{"key":"2021020207082245400_ijpp12049-bib-0015","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","article-title":"The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome","volume":"93","author":"Marsden","year":"1998","journal-title":"Addiction"},{"key":"2021020207082245400_ijpp12049-bib-0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/16066350009005590","article-title":"Assessing client satisfaction with treatment for substance use problems and the development of the treatment satisfaction questionnaire","volume":"8","author":"Marsden","year":"2000","journal-title":"Addiction Research"},{"key":"2021020207082245400_ijpp12049-bib-0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0376-8716(01)00178-8","article-title":"Changes in use of crack cocaine after drug misuse treatment: 4\u20135 year follow-up results from the National Treatment Outcome Research Study (NTORS)","volume":"66","author":"Gossop","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"2021020207082245400_ijpp12049-bib-0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2004.11.001","article-title":"Assessing competence in the use of motivational interviewing","volume":"28","author":"Moyers","year":"2005","journal-title":"J Subst Abuse Treat"},{"key":"2021020207082245400_ijpp12049-bib-0019","first-page":"139","article-title":"The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence","volume":"55","author":"Simoens","year":"2005","journal-title":"Br J Gen Pract"},{"key":"2021020207082245400_ijpp12049-bib-0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1891\/jcop.18.4.309.64002","article-title":"The emerging evidence base for motivational interviewing: a meta-analytic and qualitative inquiry","volume":"18","author":"Burke","year":"2004","journal-title":"J Cogn Psychother"},{"key":"2021020207082245400_ijpp12049-bib-0021","doi-asserted-by":"crossref","first-page":"c6325","DOI":"10.1136\/bmj.c6325","article-title":"Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and co-morbid substance misuse: randomised controlled trial","volume":"341","author":"Barrowclough","year":"2010","journal-title":"BMJ"},{"key":"2021020207082245400_ijpp12049-bib-0022","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1360-0443.2004.00743.x","article-title":"Motivational enhancement and coping skills training for cocaine abusers: effects on substance use outcomes","volume":"99","author":"Rohsenow","year":"2004","journal-title":"Addiction"},{"key":"2021020207082245400_ijpp12049-bib-0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.38338.674583.AE","article-title":"Does home based medication review keep older people out of hospital? The HOMER randomized controlled trial","volume":"330","author":"Holland","year":"2005","journal-title":"BMJ"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijpp.12049","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/22\/1\/4\/36164424\/ijpp12049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/22\/1\/4\/36164424\/ijpp12049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T08:45:39Z","timestamp":1612341939000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/22\/1\/4\/6101931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,3]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,7,3]]},"published-print":{"date-parts":[[2014,1,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ijpp.12049","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,2]]},"published":{"date-parts":[[2013,7,3]]}}}